Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Condensed Consolidated Statements of Operations [Abstract]
Revenues
Operating expenses:
Research and development	$ 1,357,394	$ 286,979	$ 2,662,403	$ 431,274
General and administrative	958,922	601,473	3,502,336	719,851
Total operating expenses	2,316,316	888,452	6,164,739	1,151,125
Loss from operations	$ (2,316,316)	(888,452)	(6,164,739)	(1,151,125)
Interest expense		30,544	3,503,301	44,509
Net loss	$ (2,316,316)	(918,996)	$ (9,668,040)	(1,195,634)
Loss attributable to noncontrolling interests		(83)		(10,956)
Loss attributable to controlling interests	$ (2,316,316)	$ (918,913)	$ (9,668,040)	$ (1,184,678)
Basic and diluted loss per common share	$ (0.03)	$ (0.01)	$ (0.12)	$ (0.02)
Basic and diluted weighted average shares outstanding	86,013,196	68,000,000	81,853,065	68,000,000